<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02844465</url>
  </required_header>
  <id_info>
    <org_study_id>CS-05000</org_study_id>
    <nct_id>NCT02844465</nct_id>
  </id_info>
  <brief_title>Stereotactic Laser Ablation for Temporal Lobe Epilepsy</brief_title>
  <acronym>SLATE</acronym>
  <official_title>Stereotactic Laser Ablation for Temporal Lobe Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser&#xD;
      ablation system for mesial temporal epilepsy (MTLE).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to evaluate the safety and efficacy of the Visualase MRI-guided&#xD;
      laser ablation system for necrotization or coagulation of epileptogenic foci in patients with&#xD;
      intractable mesial temporal lobe epilepsy.&#xD;
&#xD;
      The study will include approximately 150 adult patients with drug-resistant MTLE treated at&#xD;
      selected epilepsy centers across the United States. After the Visualase procedure, patients&#xD;
      will be followed for 12 months and evaluated for freedom from seizures, quality of life,&#xD;
      adverse events, and neuropsychological outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of qualifying adverse events</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Seizure freedom, defined as Engel Classification of Postoperative Outcome Class I</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Seizure freedom compared to historical controls</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seizure freedom, including subjects retreated with Visualase</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Boston Naming Test scores</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Rey Auditory Verbal Learning Test scores</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Short Form-36 (SF-36) Health Survey scores</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life in Epilepsy (QOLIE-31) scores</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Temporal Lobe Epilepsy</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Visualase MRI-guided laser ablation procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Visualase MRI-Guided Laser Ablation</intervention_name>
    <description>All subjects will undergo MRI-guided laser ablation of the amygdala and hippocampus with the Visualase System.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Visualase System</other_name>
    <other_name>Visualase procedure</other_name>
    <other_name>Laser interstitial thermal therapy</other_name>
    <other_name>Stereotactic laser ablation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of drug-resistant mesial temporal lobe epilepsy (MTLE)&#xD;
&#xD;
          -  If the subject has a vagus nerve stimulator (VNS), must have failed to achieve&#xD;
             sustained seizure freedom with the VNS implanted for at least 6 months&#xD;
&#xD;
          -  On stable antiepileptic drugs (AEDs) (and/or stable VNS setting, if applicable) and&#xD;
             compliant with medication use&#xD;
&#xD;
          -  An average of at least 1 complex partial or secondarily generalized seizure compatible&#xD;
             with MTLE per month&#xD;
&#xD;
          -  Seizure symptoms and/or auras compatible with MTLE&#xD;
&#xD;
          -  Video EEG shows evidence of seizures from one temporal lobe consistent with MTLE&#xD;
&#xD;
          -  MRI has evidence consistent with mesial temporal lobe sclerosis&#xD;
&#xD;
          -  Willing and able to remain on stable AEDs (and stable VNS setting, if applicable) for&#xD;
             12 months following the Visualase procedure&#xD;
&#xD;
          -  Willing and able to comply with protocol requirements&#xD;
&#xD;
          -  Able to complete study assessments in English or Spanish language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling or unable to sign the study informed consent form&#xD;
&#xD;
          -  Pregnant or intends to become pregnant during the course of the study&#xD;
&#xD;
          -  Currently implanted with a device contraindicating MRI&#xD;
&#xD;
          -  Progressive brain lesions and/or tumors not associated with epileptic disease state&#xD;
&#xD;
          -  History of previous intracranial surgery for treatment of epileptic seizures&#xD;
&#xD;
          -  Persistent extra-temporal or predominant contralateral focal interictal spikes or&#xD;
             slowing, or generalized interictal spikes on EEG&#xD;
&#xD;
          -  Seizures with contralateral or extra-temporal ictal onset on EEG&#xD;
&#xD;
          -  Aura and/or ictal behavior suggest an extra-temporal focus&#xD;
&#xD;
          -  MRI evidence of epileptogenic, extra-temporal lesions, dual pathology in the temporal&#xD;
             lobe, or contralateral hippocampal MRI increased signal and/or loss of architecture&#xD;
&#xD;
          -  If additional testing has been performed, results are discordant with the seizure&#xD;
             focus scheduled for ablation&#xD;
&#xD;
          -  Non-compliance with AED requirements&#xD;
&#xD;
          -  IQ &lt; 70&#xD;
&#xD;
          -  Dementia or other progressive neurological disease&#xD;
&#xD;
          -  Unstable major psychiatric illness, psychogenic non-epileptic seizures, or medical&#xD;
             illness that would contraindicate the Visualase procedure or affect the&#xD;
             neuropsychological assessments&#xD;
&#xD;
          -  Participation in other research that may potentially interfere with SLATE endpoint(s)&#xD;
&#xD;
          -  Allergy to gadolinium&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Gross, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Sperling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Senior Clinical Research Manager</last_name>
    <email>rs.slatestudy@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92688</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Heim, BSN, RN, CCRP</last_name>
      <phone>949-764-8190</phone>
      <email>laura.heim@hoag.org</email>
    </contact>
    <investigator>
      <last_name>Vivek Mehta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bharati Sanjanwala, MS</last_name>
      <phone>650-721-2830</phone>
      <email>bharatis@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anthony Bet</last_name>
      <phone>650-683-5823</phone>
      <email>abet0915@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vivek P Buch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Seaton</last_name>
      <email>margaret.seaton@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Knowlton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela David Gerecht, PhD</last_name>
      <phone>303-724-4134</phone>
      <email>Pamela.DavidGerecht@ucanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Steven G. Ojemann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Letitia Fisher</last_name>
      <phone>305-243-7108</phone>
      <email>lfisher@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Jagid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvan Bamps, PhD</last_name>
      <phone>404-778-7673</phone>
      <email>yvan.bamps@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Cabaniss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guadalupe Castro</last_name>
      <phone>773-834-6122</phone>
      <email>gcastro@surgery.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Peter C. Warnke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Perrey, RN, BSN</last_name>
      <phone>317-963-7505</phone>
      <email>lperrey@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Vicenta Salanova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony Stanfield</last_name>
      <phone>415-502-0965</phone>
      <email>astanfi1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joon-Yi Kang, MD</last_name>
      <phone>410-955-2822</phone>
    </contact_backup>
    <investigator>
      <last_name>Joon-Yi Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Tundo, RN, BSN</last_name>
      <phone>313-916-1102</phone>
      <email>kciach1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Jason Schwalb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karla Crockett</last_name>
      <phone>507-538-9140</phone>
      <email>crockett.karla@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Jamie Van Gompel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Jeffreys</last_name>
      <phone>603-650-3834</phone>
      <email>charlotte.a.jeffreys@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Joshua Aronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers University - Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asha Cilly, MSN</last_name>
      <phone>732-235-7342</phone>
      <email>ac1659@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Nazir</last_name>
      <phone>516-375-9053</phone>
      <email>snazir1@northwell.edu</email>
    </contact>
    <contact_backup>
      <last_name>June Taylor, NP</last_name>
      <phone>516-570-4438</phone>
      <email>ptaylor@northwell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ashesh D Mehta, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriella Tosti-D'Antonio, DNP</last_name>
      <email>gmt2115@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Guy M. McKhann II, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Woodard</last_name>
      <phone>336-713-9382</phone>
      <email>vwoodard@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Gautam Popli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katy Groezinger, BSN, RN</last_name>
      <phone>614-566-1255</phone>
      <email>katy.groezinger@ohiohealth.com</email>
    </contact>
    <investigator>
      <last_name>Girish Hiremath, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; University Science</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael McGehee</last_name>
      <phone>503-494-4988</phone>
      <email>mcgehee@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Roberts</last_name>
      <phone>215-503-7605</phone>
      <email>aaron.roberts@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Sperling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica A. Johnson, MSN, NP-C</last_name>
      <phone>713-500-5443</phone>
      <email>Jessica.A.Johnson@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Nitin Tandon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Harborview</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Steele</last_name>
      <phone>206-744-2336</phone>
      <email>steelejl@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Shahin Hakimian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2016</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>laser ablation</keyword>
  <keyword>Visualase</keyword>
  <keyword>laser interstitial thermal therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsy, Temporal Lobe</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to share individual participant data, but aggregate data for all primary and secondary endpoints will be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

